Pfizer in Global Blood Therapeutics Takeover Talks

  • Investing.com
  • Stock Market News
Pfizer in Global Blood Therapeutics Takeover Talks
Credit: © Reuters.

By Sam Boughedda

Pfizer (NYSE: PFE ) is reportedly in talks to acquire Global Blood Therapeutics Inc (NASDAQ: GBT ), according to a report by The Wall Street Journal Friday.

The news follows Thursday's report by Bloomberg that large pharmaceutical companies are eyeing a potential takeover deal for Global Blood Therapeutics.

Pfizer is said to be discussing a potential $5 billion takeover of Global Blood Therapeutics. The company's drug for sickle-cell disease was recently approved. The move would bolster Pfizer's portfolio and pipeline.

The WSJ said its sources told them Pfizer is aiming to seal a deal for GBT within the coming days. However, there is no guarantee of a deal, and other companies are said to be "still in the mix."

GBT shares popped 41% following Thursday's report and have gained another 9.5% Friday.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles